Nuvation Bio Inc. (NUVB) came out with a quarterly loss of $0.16 per share in line with the Zacks Consensus Estimate. This compares to loss of$0.07 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.14 per share when it actually produced a loss of$0.15, delivering a surprise of -7.14%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.Nuvation Bio, which belongs to the ...